• Text Resize A A A
  • Print Print
  • Share Share on facebook Share on twitter Share

Hepatitis Blog Archives

All | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

CDC Know More Hepatitis Campaign Poster
Dr. Richard Wolitski describes federal opportunities for addressing viral hepatitis.
Tagged: Hepatitis C
Image of Kyung Hee Choi
In a study of 11,177 Asian Americans screened for hepatitis B, Holy Name Medical Center found a 3.2% prevalence rate; linkage to care is an ongoing challenge.
Tagged: Hepatitis B
San Francisco Department of Health seal
San Francisco Department of Public Health’s innovative primary care-based HCV treatment program expands HCV treatment access to vulnerable populations.
Tagged: Hepatitis C
HRSA logo
HRSA’s HIV/AIDS Bureau has awarded a new initiative to improve hepatitis C virus (HCV) services among HIV/HCV coinfected people of color, funded under the FY 2016 Secretary’s Minority AIDS Initiative Fund.
Tagged: Hepatitis C |
Image of the seal for the Executive Office of the President of the United States
Dr. Sean Allen, White House Office of National Drug Control Policy, describes strategies for preventing the spread of infectious diseases due to substance use
Tagged: Hepatitis C
Federal Bureau of Prisons seal
The Federal Bureau of Prisons has released an October 2016 update to their guidance document, Evaluation and Management of Chronic Hepatitis C Virus Infection.
Tagged: Hepatitis C
Read a blog post about the latest CDC Vital Signs on syringe services.
According to the latest CDC Vital Signs, only 1 in 4 people who inject drugs (PWID) in 22 US cities reported getting all their needles from sterile sources.
World AIDS Day logo
December 1st is World AIDS Day, and provides an opportunity to discuss the unique issues related to HIV and viral hepatitis coinfection, as well as strategies for moving forward.
HBI-DC receiving a a 2016 White House Hepatitis Testing Day award
Jane Pan, Executive Director of Hepatitis B Initiative of Washington, D.C. (HBI-DC), and a 2016 White House Hepatitis Testing Day Awardee, describes HBI-DC’s 10 years of community-based direct services.
FDA Logo
On November 10, 2016, the U.S. Food and Drug Administration (FDA) approved Vemlidy® (tenofovir alafenamide), a once-daily oral treatment for chronic hepatitis B infection in adults.
Tagged: Hepatitis B


  • of 8
  • >